Former FDA Chief Counsel Expects Lawsuits Over Agency's LDT Proposal
BRG is home to renowned thought leaders and experts considered authorities in their fields of work. Our timely research and perspectives provide analysis and insights on the most important issues facing the industries and organizations we serve.
Dan Troy comments that clinical labs will likely file lawsuits after the US Food and Drug Administration’s recent proposal to regulate lab-developed tests (LDTs), and that those lawsuits will have some chance of success. Regardless of the outcome, he expects a legal battle before the FDA’s proposed rule can be put into effect.
Related Professionals
Prepare for what's next.
ThinkSet magazine, a BRG publication, provides nuanced, multifaceted thinking and expert guidance that help today’s business leaders adopt a more strategic, long-term mindset to prepare for what’s next.